Roche Inks Discovery, Development Pacts | June 15, 2009 Issue - Vol. 87 Issue 24 | Chemical & Engineering News
Volume 87 Issue 24 | p. 16 | Concentrates
Issue Date: June 15, 2009

Roche Inks Discovery, Development Pacts

Department: Business
Keywords: Roche, Raptor Pharmaceuticals, SeqWright

Roche and Raptor Pharmaceuticals have entered a collaborative research agreement in which Roche will fund studies of the therapeutic delivery of select molecules across the blood-brain barrier (BBB) using Raptor's proprietary NeuroTrans BBB transporter platform. The agreement grants Roche exclusive worldwide license to NeuroTrans for use in delivering therapeutic and diagnostic molecules. Roche also signed a collaboration agreement with SeqWright, a DNA-sequencing firm, and the University of Miami's Miller School of Medicine to identify possible genetic variants associated with dilated cardiomyopathy, a disease of the heart muscle. Financial terms were not disclosed.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment